SciVision Biotech Posts Strong Q2 2024 Resultsby Lilu Anderson 11.08.2024SciVision Biotech reports a 33% net income increase in Q2 2024, EPS rises to NT$1.00 boosting investor confidence.
ADENTRA Navigates Growth Amid Sales Declineby Mark Eisenberg 10.08.2024ADENTRA shows resilience with strategic growth, a 21.7% margin, and 43.2% EPS increase despite a 6.2% sales drop.
Goldman Sachs BDC Sees Q2 Mixed Results, Declares Dividendby Mark Eisenberg 10.08.2024Goldman Sachs BDC reports Q2 mixed results, dividend $0.45/share, net income up, asset value down, plans for strategic investments.
Organogenesis Q2 Revenue Surpasses Forecasts at $130Mby Mark Eisenberg 10.08.2024Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
CFAA Ambiguity Puts AI Researchers at Riskby Lilu Anderson 09.08.2024Harvard experts debate if prompt injections in AI breach the CFAA, revealing a legal gray area.
Choice Hotels Reports Record Q2 Earnings Surgeby Mark Eisenberg 09.08.2024Choice Hotels posts record Q2 earnings with 22% growth in global room pipeline. Upscale growth and strategic expansions lead the ...
Moody’s Downgrades Intel’s Credit Ratingby Mark Eisenberg 09.08.2024Moody's downgrades Intel's rating to BAA1, citing profitability concerns and changes outlook to negative.
Solana Set to Outperform Bitcoin Short Termby John Darbie 09.08.2024Solana's potential to outshine Bitcoin short-term is drawing attention, with insights on CRV's long-term growth potential.
Bitcoin Surges 10% Amid Bullish Market Trendsby John Darbie 09.08.2024Bitcoin's market cap climbs to $1,205.3B, marking a significant gain amid volatile cryptocurrency trends.
FTX Ordered to Pay $12.7 Billion to Customersby John Darbie 09.08.2024Bankrupt crypto exchange FTX must pay $12.7B to customers, per US CFTC. The agreement prioritizes customer repayment.